The setup is less about one quarter of execution and more about a credibility reset: the market has been pricing a world where generative AI disintermediates legacy software, and this print argues the opposite for firms with entrenched workflows and distribution. The key mechanism is that AI is not yet a seat-killer here; it is becoming an attach product that can lift mix and defend pricing, which is the right kind of AI exposure for a mature software franchise. The market should, however, discount the non-operating investment mark heavily — that boosts optics, not enterprise value.

Second-order winners are the adjacent layers that enable enterprise deployment: if AI features are embedded into CRM workflows, implementation partners, systems integrators, and cloud usage all get incremental pull-through. The more important loser set is the long-tail of point solutions in sales engagement and customer-service automation that rely on being “good enough” at a single workflow; once the incumbent bundles AI into the core stack, those vendors face slower ACV expansion and higher churn. Over 1-3 months, the real tell is whether current RPO and net-new AI bookings convert into sustained cRPO growth, not whether one quarter’s margin benefited from operating discipline.

Contrarian view: the stock may be celebrating the wrong line item. If the AI product ramp is still small relative to the core subscription base, the move can fade once investors strip out the Anthropic gain and ask whether guidance simply reverts to low-double-digit growth. The risk/reward flips if the next quarter shows Agentforce-style revenue becoming a meaningful driver of backlog and expansion; absent that, this looks like a multiple repair trade rather than a durable re-rating. In other words, the thesis is valid, but the burden of proof shifts immediately to conversion metrics over the next 1-2 quarters.